Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter
- PMID: 12816724
- PMCID: PMC1920687
- DOI: 10.1215/S1152851702000510
Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter
Abstract
The interleukin 13 alpha 2 receptor (IL-13Ra2) has been shown to be expressed in most malignant glioblastoma cells. Recent studies suggest that IL-13Ra2 serves as a dominant negative inhibitor or a decoy receptor for IL-13. To investigate the transcriptional regulation of this receptor, we cloned and characterized the promoter for the human IL-13Ra2 gene. Our results demonstrate that this promoter contains three TATA boxes and one CCAAT site. Several putative transcriptional factor binding sites for nuclear factor of activated T cells 1, AP1 (c-JUN and c-FOS), AP2, GABP, OCT1, GATA3, PRE, and C-ETS1 were predicted in the promoter region. Using the secreted alkaline phosphate reporter gene assay, we investigated the functional activity of the human IL-13Ra2 promoter by transient transfection in glioma cell lines U118, U87, and T98, which differ in their expression of the human IL-13Ra2 protein. The different secreted alkaline phosphate activities among these 3 cell lines suggest that the expression of human IL-13Ra2 is regulated at the transcriptional level. Methylation analysis showed that expression of IL-13Ra2 may not be the result of methylation of the CpG dinucleotides in the promoter region of the gene. Deletion analysis identified a 64 base pair (bp) region that is necessary for human IL-13Ra2 promoter activity. This 64-bp sequence contains cis-elements for AP1, nuclear factor of activated T cells, and AP2. The possible role of AP1 in the regulation of human IL-13Ra2 promoter activity was suggested by in vitro mutagenesis and c-JUN N-terminal kinase inhibition analysis.
Similar articles
-
Structural characterization of the human interleukin-13 receptor alpha1 gene promoter.Biochem Biophys Res Commun. 1999 Nov 19;265(2):387-94. doi: 10.1006/bbrc.1999.1701. Biochem Biophys Res Commun. 1999. PMID: 10558877
-
NFAT and AP1 are essential for the expression of a glioblastoma multiforme related IL-13Ra2 transcript.Cell Oncol. 2010;32(5-6):313-29. doi: 10.3233/CLO-2010-0524. Cell Oncol. 2010. PMID: 20448330 Free PMC article.
-
Identification and characterization of a functional promoter region in the human eosinophil IL-5 receptor alpha subunit gene.J Biol Chem. 1995 Jan 20;270(3):1462-71. doi: 10.1074/jbc.270.3.1462. J Biol Chem. 1995. PMID: 7836416
-
Interleukin-5 receptor alpha subunit gene regulation in human eosinophil development: identification of a unique cis-element that acts lie an enhancer in regulating activity of the IL-5R alpha promoter.Curr Top Microbiol Immunol. 1996;211:173-87. doi: 10.1007/978-3-642-85232-9_18. Curr Top Microbiol Immunol. 1996. PMID: 8585949 Review.
-
Transient transfection and adrenergic receptor promoter analysis.Methods Mol Biol. 2000;126:235-9. doi: 10.1385/1-59259-684-3:235. Methods Mol Biol. 2000. PMID: 10685415 Review. No abstract available.
Cited by
-
Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide.Cancers (Basel). 2023 May 16;15(10):2772. doi: 10.3390/cancers15102772. Cancers (Basel). 2023. PMID: 37345109 Free PMC article.
-
Recent developments on immunotherapy for brain cancer.Expert Opin Emerg Drugs. 2012 Jun;17(2):181-202. doi: 10.1517/14728214.2012.679929. Epub 2012 Apr 25. Expert Opin Emerg Drugs. 2012. PMID: 22533851 Free PMC article. Review.
-
IL-13 receptor isoforms: breaking through the complexity.Curr Allergy Asthma Rep. 2007 Sep;7(5):338-45. doi: 10.1007/s11882-007-0051-x. Curr Allergy Asthma Rep. 2007. PMID: 17697639 Review.
-
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer.J Transl Med. 2011 Apr 8;9:37. doi: 10.1186/1479-5876-9-37. J Transl Med. 2011. PMID: 21477288 Free PMC article.
-
Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.Tumour Biol. 2016 Mar;37(3):3247-55. doi: 10.1007/s13277-015-4080-0. Epub 2015 Oct 4. Tumour Biol. 2016. PMID: 26433389 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous